These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7201459)

  • 1. cis-platinum and 5-fluorouracil as initial therapy in advanced epidermoid cancers of the head and neck.
    Weaver A; Fleming S; Vandenberg H; Drelichman A; Jacobs J; Kinzie J; Loh JJ; Al-Sarraf M
    Head Neck Surg; 1982; 4(5):370-3. PubMed ID: 7201459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modified combination chemotherapy of cisplatin and 5-fluorouracil in squamous cell carcinomas of the head and neck.
    Furukawa S; Tsukuda M; Mochimatsu I; Kokatsu T; Satoh H; Sakumoto M
    Auris Nasus Larynx; 1994; 21(3):181-5. PubMed ID: 7872895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neo-adjuvant chemo-(immuno-)therapy of advanced squamous-cell head and neck carcinoma: a multicenter, phase III, randomized study comparing cisplatin + 5-fluorouracil (5-FU) with cisplatin + 5-FU + recombinant interleukin 2.
    Mantovani G; Gebbia V; Airoldi M; Bumma C; Contu P; Bianchi A; Ghiani M; Dessì D; Massa E; Curreli L; Lampis B; Lai P; Mulas C; Testa A; Proto E; Cadeddu G; Tore G
    Cancer Immunol Immunother; 1998 Nov; 47(3):149-56. PubMed ID: 9829840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cisplatin, fluorouracil, and L-leucovorin induction chemotherapy for locally advanced head and neck cancer: the M.D. Anderson Cancer Center experience.
    Papadimitrakopoulou VA; Dimery IW; Lee JJ; Perez C; Hong WK; Lippman SM
    Cancer J Sci Am; 1997; 3(2):92-9. PubMed ID: 9099459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cis-platinum chemotherapy in head and neck cancers.
    Jacobs C; Bertino JR; Goffinet DR; Fee WE; Goode RL
    Otolaryngology; 1978; 86(5):ORL-780-3. PubMed ID: 114948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of 96-hour infusion fluorouracil plus cisplatin in combination with alpha interferon for patients with advanced squamous cell carcinoma of the head and neck: a Southwest Oncology Group study.
    Hussain M; Benedetti J; Smith RE; Rodriguez GI; Schuller D; Ensley J
    Cancer; 1995 Oct; 76(7):1233-7. PubMed ID: 8630903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial of cisplatin (CACP) + 5-fluorouracil (5-FU) infusion and CACP + 5-FU bolus for recurrent and advanced squamous cell carcinoma of the head and neck.
    Kish JA; Ensley JF; Jacobs J; Weaver A; Cummings G; Al-Sarraf M
    Cancer; 1985 Dec; 56(12):2740-4. PubMed ID: 3902199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The activity of a single-agent 5-fluorouracil infusion in advanced and recurrent head and neck cancer.
    Tapazoglou E; Kish J; Ensley J; Al-Sarraf M
    Cancer; 1986 Mar; 57(6):1105-9. PubMed ID: 3943034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant chemotherapy with cis-diamminodichloroplatinum II and 120-hour infusion 5-fluorouracil in Stage III and IV squamous cell carcinoma of the head and neck.
    Decker DA; Drelichman A; Jacobs J; Hoschner J; Kinzie J; Loh JJ; Weaver A; Al-Sarraf M
    Cancer; 1983 Apr; 51(8):1353-5. PubMed ID: 6681726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical trial of cisplatin and 5-FU infusion as initial treatment for advanced squamous cell carcinoma of the head and neck.
    Kish J; Drelichman A; Jacobs J; Hoschner J; Kinzie J; Loh J; Weaver A; Al-Sarraf M
    Cancer Treat Rep; 1982 Mar; 66(3):471-4. PubMed ID: 7037180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase I study of cabazitaxel in combination with platinum and 5-fluorouracil (PF) in locally advanced squamous cell carcinoma of head and neck (LA-SCCHN).
    Camille N; Rozehnal J; Roy E; Uczkowski D; Olson A; Genden E; Teng M; Bakst R; Gupta V; Posner M; Misiukiewicz K
    Oral Oncol; 2017 Aug; 71():99-104. PubMed ID: 28688700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitomycin C, cisplatin, and 5-fluorouracil for advanced and/or recurrent head and neck squamous cell carcinomas.
    Iop A; Cartei G; Vigevani E; Clocchiatti L; Mansutti M; Sibau AM
    Am J Clin Oncol; 1997 Oct; 20(5):515-8. PubMed ID: 9345340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase II evaluation of a 3-hour infusion of paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group study 0007.
    Worden FP; Moon J; Samlowski W; Clark JI; Dakhil SR; Williamson S; Urba SG; Ensley J; Hussain MH;
    Cancer; 2006 Jul; 107(2):319-27. PubMed ID: 16779801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bleomycin and cis-platinum with or without mitomycin C in 110 previously untreated patients with head and neck cancer.
    Israel L; Aguilera J; Soudant J; Penot JC; Breau JL; Morere JF
    Am J Clin Oncol; 1983 Jun; 6(3):305-11. PubMed ID: 6189388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cis-platinum and 5-fluorouracil as induction therapy for advanced head and neck cancer.
    Weaver A; Flemming S; Kish J; Vandenberg H; Jacob J; Crissman J; Al-Sarraf M
    Am J Surg; 1982 Oct; 144(4):445-8. PubMed ID: 6889819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized controlled phase II comparison study of concurrent chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil versus CCRT with cisplatin, 5-fluorouracil, methotrexate and leucovorin in patients with locally advanced squamous cell carcinoma of the head and neck.
    Tsukuda M; Ishitoya J; Matsuda H; Horiuchi C; Taguchi T; Takahashi M; Nishimura G; Kawakami M; Watanabe M; Niho T; Kawano T; Ikeda Y; Sakuma Y; Shiono O; Komatsu M
    Cancer Chemother Pharmacol; 2010 Sep; 66(4):729-36. PubMed ID: 20033810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction chemotherapy with cis-platinum and 5-fluorouracil for squamous cell carcinoma of the head and neck.
    Thyss A; Schneider M; Santini J; Caldani C; Vallicioni J; Chauvel P; Demard F
    Br J Cancer; 1986 Nov; 54(5):755-60. PubMed ID: 3801272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cisplatin, 5-fluorouracil, and high-dose folinic acid in patients with advanced unresectable head and neck cancer.
    Alba E; Sanchez-Chaparro MA; Alonso L; Ribelles N; Ramon Delgado J; Rueda A; Pablo Tenllado P; Solano J; Urquiza R
    Am J Clin Oncol; 1996 Apr; 19(2):140-3. PubMed ID: 8610637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent cis-platinum and radiation with or without surgery for advanced head and neck cancer.
    Glicksman AS; Slotman G; Doolittle C; Clark J; Koness J; Coachman N; Posner M; DeRosa E; Wanebo H
    Int J Radiat Oncol Biol Phys; 1994 Dec; 30(5):1043-50. PubMed ID: 7961010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous cisplatin (24-hour) and 5-fluorouracil (120-hour) infusion in recurrent head and neck squamous cell carcinoma.
    Choksi AJ; Hong WK; Dimery IW; James P; Guillamondegui OM; Byers RM
    Cancer; 1988 Mar; 61(5):909-12. PubMed ID: 3338056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.